Shares of The Chemours Company (NYSE:CC – Get Free Report) hit a new 52-week low on Tuesday after Barclays lowered their price target on the stock from $23.00 to $19.00. Barclays currently has an equal weight rating on the stock. Chemours traded as low as $14.94 and last traded at $15.39, with a volume of 1464175 shares changing hands. The stock had previously closed at $16.15.
CC has been the topic of a number of other reports. Truist Financial initiated coverage on Chemours in a research note on Tuesday, January 28th. They set a “buy” rating and a $27.00 target price on the stock. BMO Capital Markets lowered their price objective on shares of Chemours from $34.00 to $27.00 and set an “outperform” rating for the company in a research note on Wednesday, February 19th. Mizuho cut their target price on shares of Chemours from $22.00 to $21.00 and set a “neutral” rating on the stock in a research note on Tuesday, January 7th. The Goldman Sachs Group decreased their price target on shares of Chemours from $24.00 to $21.00 and set a “neutral” rating for the company in a research report on Tuesday, January 7th. Finally, Morgan Stanley cut their price objective on Chemours from $25.00 to $22.00 and set an “equal weight” rating on the stock in a research report on Monday, January 13th. Five equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Chemours currently has a consensus rating of “Hold” and an average target price of $23.11.
Read Our Latest Stock Report on Chemours
Institutional Inflows and Outflows
Chemours Trading Down 5.2 %
The company has a debt-to-equity ratio of 6.70, a quick ratio of 0.92 and a current ratio of 1.68. The business’s 50-day moving average is $18.03 and its two-hundred day moving average is $18.91. The stock has a market capitalization of $2.29 billion, a PE ratio of 26.90 and a beta of 1.81.
Chemours (NYSE:CC – Get Free Report) last released its quarterly earnings data on Tuesday, February 18th. The specialty chemicals company reported $0.11 EPS for the quarter, topping analysts’ consensus estimates of $0.10 by $0.01. Chemours had a net margin of 1.51% and a return on equity of 26.54%. The firm had revenue of $1.36 billion for the quarter, compared to the consensus estimate of $1.37 billion. As a group, equities research analysts anticipate that The Chemours Company will post 2.03 earnings per share for the current year.
Chemours Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Friday, March 14th. Investors of record on Friday, February 28th will be paid a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a yield of 6.53%. The ex-dividend date of this dividend is Friday, February 28th. Chemours’s payout ratio is currently 175.44%.
About Chemours
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.
Featured Stories
- Five stocks we like better than Chemours
- 5 Top Rated Dividend Stocks to Consider
- Home Depot Turns a Corner: New Highs Likely This Year
- What is a Dividend King?
- February’s Top 3 Stock Upgrades: What Investors Need to Know
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- 2 Safe-Haven Stocks Shielded From Import Tariffs
Receive News & Ratings for Chemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemours and related companies with MarketBeat.com's FREE daily email newsletter.